CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

FY: Sep 30 2005

FY: Sep 30 2004

FY: Sep 30 2004

FY: Sep 30 2003

FY: Sep 30 2001

FY: Sep 30 2002

FY: Sep 30 2002

FY: Sep 30 2001

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Certification of termination of registration of a class of securities (Section 12(g))

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers

Withdrawal of a registration statement

Post-effective amendment to an American depositary receipts registration statement

No description available

ASTRAZENECA PLC

GENZYME CORP

ASTRAZENECA PLC

ASTRAZENECA PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

ASTRAZENECA PLC

ASTRAZENECA PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

ASTRAZENECA PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

ASTRAZENECA PLC

ASTRAZENECA PLC

ASTRAZENECA PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

ASTRAZENECA PLC

ASTRAZENECA PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

Letter from the SEC

Letter from the SEC

No description available

No description available

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Tender offer/rights offering notification form

Tender offer/rights offering notification form

Tender offer/rights offering notification form

Tender offer/rights offering notification form